FDA OKs AstraZeneca 's first-in-class ovarian cancer drug plus companion test from Myriad
ABC News: Money, ABC News: Business
Fri, 12/19/2014 - 12:39pm
FDA OKs AstraZeneca 's first-in-class ovarian cancer drug plus companion test from Myriad